Riskpilot← Back to searchSign inGet full accessLØKEN APOTEK AS
ASActiveOrg 995704900Morgenliveien 7, 1960 LøkenRetail sale of pharmaceutical products · NACE 4773Est. 20108 employees
Revenue 2025
NOK 31,1M
-3% vs 2024
EBITDA margin
6.5%
-19% vs 2024
Equity ratio
1.7%
Financial strength
Net profit 2025
NOK 1,7M
-18% vs 2024
| Revenue | NOK 31,1M | -3% |
| EBITDA | NOK 2M | -19% |
| Net profit | NOK 1,7M | -18% |
| Total assets | NOK 6,3M | -11% |
| Equity | NOK 104K | -4% |
| Employees | 8 | — |
Legal name
LØKEN APOTEK AS
Org number
995704900
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
5. juli 2010
Share capital
NOK 100 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Selskapets formål er å eie og drive apotek og alt hva hermed står i forbindelse.
Address
Morgenliveien 7, 1960 Løken
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 22 568 | 24 193 | 27 671 | 32 249 | 31 139 |
| Staff expenses | −2 860 | −2 903 | −3 363 | −3 780 | −4 013 |
| EBITDA | 2 378 | 2 269 | 2 656 | 2 515 | 2 031 |
| Depreciation & amort. | −59 | −49 | −49 | −53 | −42 |
| EBIT | 2 319 | 2 220 | 2 608 | 2 462 | 1 989 |
| Net financials | 24 | 54 | 124 | 153 | 151 |
| Profit before tax | 2 343 | 2 274 | 2 732 | 2 615 | 2 140 |
| Tax | 512 | 492 | 596 | 575 | 474 |
| Net profit | 1 831 | 1 782 | 2 136 | 2 040 | 1 666 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 428 | 5 453 | 8 764 | 7 060 | 6 282 |
| Equity | 121 | 102 | 108 | 108 | 104 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 307 | 5 350 | 8 656 | 6 952 | 6 178 |
| Total debt | 5 307 | 5 350 | 8 656 | 6 952 | 6 178 |
EBITDA margin
6.5%
This company
15.8%
Market median
-59% vs market
20212025
Equity ratio
1.7%
This company
38.2%
Market median
-96% vs market
20212025
Return on equity
1606.6%
This company
18.4%
Market median
+8632% vs market
20212025
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20212025
Asset turnover
4.96×
This company
1.12×
Market median
+343% vs market
20212025
Debt / equity
59.59×
This company
0.62×
Market median
-9511% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KK Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2010 | |
| Board of Directors | 2010 | |
| Board of Directors | 2010 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66% | 66% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Frogner Apotekdrift As
LØKEN APOTEK AS Board members of LØKEN APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristiane Karlsen | Chief Executive Officer | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Helge Fauskrud | Board of Directors | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |